No Detail Found!

Endocrine and metabolic effects of glucagon like peptide 1 receptor agonists (GLP1RA).

Author(s)
Sanjay Kalra Department of Endocrinology, Bharti Hospital, Karnal, India
Yashdeep Gupta All India Institute of Medical Sciences, New Delhi, India
Abstract
This brief review describes the potential non-glycaemic effects and benefits of glucagon like peptide 1 receptor agonists (GLP1RA). It lists various indications in which this class of drugs has been used, and explains the rationale behind this use. The potential uses of GLP1RA extend across the entire spectrum of endocrinology and metabolism, from hypothalamic obesity to non-alcoholic steatohepatitis (NASH) to polycystic ovary syndrome (PCOS). The article also discusses and addresses endocrine-related concerns related to the GLP1RAs.
Publication Details
Page(s) 357-359
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 66, Issue: 3, Year: 2016

Request the full text from PASTIC

0

Citations

0

Downloads

132

Views